Hydroxyapatite deposition disease (Q44293): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
A doença por deposição de cristais de hidroxiapatita de cálcio é caracterizada pela presença de cristais de fosfato de cálcio básico - predominantemente hidroxiapatita - em tecidos moles periarticulares, especialmente os tendões. Essa entidade é melhor reconhecida como "tendinite calcificada" no local mais frequente de acometimento no ombro, mas manifesta-se em vários outros locais, com a denominação mais adequada de periartrite calcificada. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Calcium hydroxyapatite crystal deposition disease is characterised by the presence of basic calcium phosphate crystals - predominantly hydroxyapatite - in periarticular soft tissues, especially tendons. This entity is best recognised as "calcific tendinitis" at its most frequent site about the shoulder, but the disease involves numerous other sites and may be more appropriately termed calcific periarthritis. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/1750451396 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:FA26.1 | |||||||||||||||
| Property / CURIE: CID11:FA26.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-FA26.1 | |||||||||||||||
| Property / Canary Token: dki-india-FA26.1 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: M11.0 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 11:42, 13 August 2026
Calcium hydroxyapatite crystal deposition disease is characterised by the presence of basic calcium phosphate crystals - predominantly hydroxyapatite - in periarticular soft tissues, especially tendons. This entity is best recognised as "calcific tendinitis" at its most frequent site about the shoulder, but the disease involves numerous other sites and may be more appropriately termed calcific periarthritis.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | FA26.1 |
||
| English | Hydroxyapatite deposition disease |
Calcium hydroxyapatite crystal deposition disease is characterised by the presence of basic calcium phosphate crystals - predominantly hydroxyapatite - in periarticular soft tissues, especially tendons. This entity is best recognised as "calcific tendinitis" at its most frequent site about the shoulder, but the disease involves numerous other sites and may be more appropriately termed calcific periarthritis. |
Statements
CID11:FA26.1
0 references
dki-india-FA26.1
0 references
Concluído
0 references
13 August 2026
0 references
